Atlas Trials

Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

Clinical trial NCT00632268 · COMPLETED

Trial details

NCT number
NCT00632268
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Gastric Cancer
Start date
2008-02-01
Primary completion
2012-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.